Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merck Sharp & Dohme LLC
With
Pfizer
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants with type 2 diabetes and hypertension
Medically stable
On at least 1 (and up to 2) oral diabetes drugs
And up to 2 medicines for blood pressure control
You may not be if
Participants with type 1 diabetes
Heart attack
Stroke
Uncontrolled blood pressure
Significant kidney disease
Clareo Health | Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)
